A detailed history of Well Done, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Well Done, LLC holds 49,536 shares of ABBV stock, worth $9.59 Million. This represents 1.78% of its overall portfolio holdings.

Number of Shares
49,536
Previous 49,572 0.07%
Holding current value
$9.59 Million
Previous $9.03 Million 5.88%
% of portfolio
1.78%
Previous 1.78%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

SELL
$154.79 - $180.76 $5,572 - $6,507
-36 Reduced 0.07%
49,536 $8.5 Million
Q1 2024

Apr 18, 2024

SELL
$159.82 - $182.1 $90,458 - $103,068
-566 Reduced 1.13%
49,572 $9.03 Million
Q4 2023

Jan 18, 2024

BUY
$137.6 - $154.97 $1,376 - $1,549
10 Added 0.02%
50,138 $7.77 Million
Q3 2023

Oct 16, 2023

BUY
$133.59 - $154.65 $6,679 - $7,732
50 Added 0.1%
50,128 $7.47 Million
Q2 2023

Jul 20, 2023

SELL
$132.51 - $164.9 $1.03 Million - $1.28 Million
-7,773 Reduced 13.44%
50,078 $6.75 Million
Q1 2023

Apr 20, 2023

SELL
$144.61 - $166.54 $144 - $166
-1 Reduced -0.0%
57,851 $9.22 Million
Q4 2022

Jan 17, 2023

SELL
$138.31 - $165.87 $4,287 - $5,141
-31 Reduced 0.05%
57,852 $0
Q3 2022

Oct 14, 2022

BUY
$134.21 - $153.93 $13,421 - $15,393
100 Added 0.17%
57,883 $7.77 Million
Q2 2022

Jul 18, 2022

SELL
$137.62 - $174.96 $53,947 - $68,584
-392 Reduced 0.67%
57,783 $8.85 Million
Q1 2022

Apr 20, 2022

SELL
$131.98 - $163.75 $69,289 - $85,968
-525 Reduced 0.89%
58,175 $9.43 Million
Q4 2021

Jan 21, 2022

BUY
$107.43 - $135.93 $18,370 - $23,244
171 Added 0.29%
58,700 $7.95 Million
Q3 2021

Nov 01, 2021

SELL
$106.4 - $120.78 $32,026 - $36,354
-301 Reduced 0.51%
58,529 $6.31 Million
Q2 2021

Jul 19, 2021

SELL
$105.21 - $117.21 $13,151 - $14,651
-125 Reduced 0.21%
58,830 $6.63 Million
Q1 2021

Apr 29, 2021

SELL
$102.3 - $112.62 $51,354 - $56,535
-502 Reduced 0.84%
58,955 $6.38 Million
Q4 2020

Feb 02, 2021

BUY
$80.49 - $108.67 $563 - $760
7 Added 0.01%
59,457 $6.37 Million
Q3 2020

Oct 19, 2020

BUY
$85.91 - $100.83 $4,896 - $5,747
57 Added 0.1%
59,450 $5.21 Million
Q2 2020

Jul 20, 2020

SELL
$73.37 - $98.18 $87,383 - $116,932
-1,191 Reduced 1.97%
59,393 $5.83 Million
Q1 2020

Apr 16, 2020

SELL
$64.5 - $97.79 $94,363 - $143,066
-1,463 Reduced 2.36%
60,584 $4.62 Million
Q4 2019

Jan 29, 2020

BUY
$72.13 - $90.25 $3,317 - $4,151
46 Added 0.07%
62,047 $5.49 Million
Q3 2019

Oct 15, 2019

BUY
$62.98 - $75.72 $566 - $681
9 Added 0.01%
62,001 $4.7 Million
Q2 2019

Jul 19, 2019

BUY
$65.7 - $83.98 $525 - $671
8 Added 0.01%
61,992 $4.51 Million
Q1 2019

May 09, 2019

SELL
$77.14 - $90.79 $1,465 - $1,725
-19 Reduced 0.03%
61,984 $5 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $43,751 - $53,957
-562 Reduced 0.9%
62,003 $5.72 Million
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $7,646 - $8,500
86 Added 0.14%
62,565 $5.92 Million
Q2 2018

Aug 03, 2018

BUY
$89.78 - $106.23 $25,587 - $30,275
285 Added 0.46%
62,479 $5.79 Million
Q1 2018

May 11, 2018

SELL
$92.01 - $123.21 $9,201 - $12,321
-100 Reduced 0.16%
62,194 $5.89 Million
Q4 2017

Feb 09, 2018

SELL
$89.56 - $98.21 $135,593 - $148,689
-1,514 Reduced 2.37%
62,294 $6.03 Million
Q3 2017

Oct 26, 2017

BUY
$69.85 - $89.22 $4.46 Million - $5.69 Million
63,808
63,808 $5.67 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $342B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Well Done, LLC Portfolio

Follow Well Done, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Well Done, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Well Done, LLC with notifications on news.